AHRQ releases draft review of antipsychotics

HHS's Agency for Healthcare Research and Quality released a draft review of the comparative effectiveness of antipsychotic drugs for pediatric and young adult populations. The agency said there is "moderate" evidence that second generation antipsychotics have superior symptom improvement and inferior adverse event profiles compared to placebo. AHRQ said data were too limited to make definite conclusions on the relative differences between various antipsychotics. ...